Intermittent Positive-Pressure Ventilation

Subscribe to Selected New Research on Intermittent Positive-Pressure Ventilation

547 relevant articles (34 outcomes, 49 trials/studies) found for this Therapy

Description: Application of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator.

Also Known As:

Biphasic Intermittent Positive Airway Pressure; Inspiratory Positive Pressure Ventilation; Intermittent Positive Pressure Ventilation; Positive-Pressure Ventilation, Inspiratory; Positive-Pressure Ventilation, Intermittent; Ventilation, Inspiratory Positive-Pressure; Ventilation, Intermittent Positive Pressure; IPPV; Inspiratory Positive-Pressure Ventilation; Ventilation, Intermittent Positive-Pressure

Relationship Network

Therapy Context: Research Results

Therapeutics: 6127

Respiratory Therapy: 502

Artificial Respiration: 8558

Positive-Pressure Respiration: 2768

Intermittent Positive-Pressure Ventilation: 547

Experts

1.	Bhandari, Vineet: 2 articles (05/2006 - 08/2004)
2.	Lemyre, B: 2 articles (01/2002 - 01/2000)
3.	Davis, P G: 2 articles (01/2002 - 01/2000)
4.	Lampland, Andrea L: 1 article (01/2008)
5.	Mammel, Mark C: 1 article (01/2008)
6.	Swanson, Elizabeth C: 1 article (01/2008)
7.	Worwa, Cathy T: 1 article (01/2008)
8.	Meyers, Patricia A: 1 article (01/2008)
9.	Tewari, Prabhat: 1 article (12/2006)
10.	Mittal, Pramod: 1 article (12/2006)

Related Diseases

1.	Respiratory Insufficiency (Respiratory Failure) 04/28/1997 - "BACKGROUND: Volume controlled intermittent ventilation (IPPV) via face mask is a treatment of proven efficacy for chronic respiratory failure (CRF). " 01/01/1994 - "OBJECTIVE: The aim of this study was to assess whether non-invasive positive pressure ventilation delivered intermittently (Ni-IPPV) by means of a facial or nasal mask is beneficial in haematological patients suffering from acute respiratory failure. " 01/01/1995 - "Nasal intermittent positive pressure ventilation (NIPPV) represents a major advance in the management of respiratory failure. " 10/01/1997 - "Noninvasive intermittent positive pressure ventilation (NIPPV) via a nasal or facial mask is an effective treatment of hypercapnic acute respiratory failure (ARF) caused by various diseases preventing endotracheal intubation (ETI) in 60-90% of patients. " 05/01/1993 - "BACKGROUND--Intermittent positive pressure ventilation applied through a nasal mask has been shown to be useful in the treatment of chronic respiratory insufficiency. " Order ALL the reference details at left...
2.	Chronic Obstructive Pulmonary Disease (COPD) 09/01/1996 - "In COPD with ARF, adding intermittent positive pressure ventilation to mask-CPAP results in an additional improvement in WOB and is highly effective in correcting gas exchange abnormalities. " 05/01/1992 - "CONCLUSIONS: Nasal intermittent positive pressure ventilation can be used effectively at home during sleep in selected patients with chronic obstructive lung disease. " 07/01/2002 - "The objective of the study was, first, to compare the outcome of episodes of acute exacerbation of chronic obstructive pulmonary disease treated with mask intermittent positive-pressure ventilation (MIPPV) in patients with home MIPPV and in patients without home ventilatory support and, second, for each category of patients, to compare patients successfully ventilated with MIPPV with those who failed with MIPPV. " 05/01/2002 - "STUDY OBJECTIVES: Noninvasive intermittent positive-pressure ventilation (NIPPV) may improve exercise performance in COPD patients. " 12/01/1997 - "The aim of this study was to determine the effect of domiciliary nasal intermittent positive pressure ventilation (NIPPV) on lung function and quality of life in hypercapnic patients with chronic obstructive pulmonary disease (COPD). " Order ALL the reference details at left...
3.	Apnea 02/01/1994 - "We conclude that: (1) TRIO does not increase convective gas transfer from the acini compared to apnea; and (2) transfer of gas out of the acini due to cardiogenic oscillations is a very small portion of the total gas eliminated during IPPV." 11/01/1998 - "The efficacy of nasal intermittent positive pressure ventilation (NIPPV) in treating apnea of prematurity was evaluated. " 11/01/1998 - "Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity." 11/01/1988 - "Previous studies have shown that normal arterial PCO2 can be maintained during apnea in anesthetized dogs by delivering a continuous stream of inspired ventilation through cannulas aimed down the main stem bronchi, although this constant-flow ventilation (CFV) was also associated with a significant increase in ventilation-perfusion (VA/Q) inequality, compared with conventional mechanical ventilation (IPPV). " 10/01/2004 - "OBJECTIVE: Nasal intermittent positive pressure ventilation (NIPPV) has widely been used in neonates to prevent extubation failure and apnea. " Order ALL the reference details at left...
4.	Hypoventilation 12/01/2000 - "Long-term nocturnal nasal intermittent positive pressure ventilation (NIPPV) has beneficial effects on daytime PaCO2 in patients with chronic alveolar hypoventilation. " 12/01/2000 - "Ventilatory response to CO2 re-breathing before and after nocturnal nasal intermittent positive pressure ventilation in patients with chronic alveolar hypoventilation." 04/01/1999 - "Beside the improvement of life quality and extension of life time the aim of IPPV is a reduction of the secondary effects of chronic hypoventilation in order to stabilize the symptoms. " 06/01/1996 - "Major advantages include correction of hypoventilation during autonomous breathing time that is usually sufficient to permit patients to resume their activities of daily living without need for ventilatory assistance during the day and efficacy comparable to that of intermittent positive pressure ventilation via an indwelling tracheostomy tube, without the inconveniences (tracheostomy is always available if necessary)." 08/01/1995 - "Normal pregnancy in primary alveolar hypoventilation treated with nocturnal nasal intermittent positive pressure ventilation." Order ALL the reference details at left...
5.	Lung Diseases (Lung Disease) 01/01/2005 - "BACKGROUND: Cohort studies (Avery 1987; Jonsson 1997) have suggested that early post-natal nasal continuous positive airways pressure (CPAP) may be beneficial in reducing the need for intubation and intermittent positive pressure ventilation, and in preventing chronic lung disease in preterm or low birth weight infants. " 01/01/2005 - "OBJECTIVES: To determine if prophylactic nasal CPAP commenced soon after birth regardless of respiratory status in the very preterm or very low birth weight infant reduces the use of IPPV and the incidence of chronic lung disease (CLD) without adverse effects. " 06/01/2004 - "There is evolving evidence that volutrauma associated with IPPV, especially in the premature infant, may induce changes in the lung which can lead to chronic lung disease. " 04/01/2004 - "It reviews the use of continuous positive airway pressure and the prevention of chronic lung disease and the use of nasal intermittent positive pressure ventilation and the difficult area of weaning from continuous positive airway pressure. " 01/01/2000 - "OBJECTIVES: To determine if prophylactic nasal continuous positive airways pressure (CPAP) commenced soon after birth regardless of respiratory status in the very preterm or very low birth weight infant reduces the use of IPPV and the incidence of chronic lung disease (CLD) without adverse effects. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Oxygen
2.	Anti-Bacterial Agents (Antibiotics)
3.	Indomethacin (Indometacin)
4.	Gases
5.	Anesthetics (Anesthetic Agents)
6.	Alfaxalone Alfadolone Mixture
7.	alpha-Glucosidases (Acid Maltase)
8.	alphadolone (alfadolone)
9.	alphaxalone (alfaxalone)
10.	Oleic Acid (Oleate)

Related Therapies and Procedures

1.	Intermittent Positive-Pressure Ventilation
2.	Continuous Positive Airway Pressure
3.	Artificial Respiration (Mechanical Ventilation)
4.	Tracheostomy
5.	Positive-Pressure Respiration (PEEP)

Best Treatments:
Research Summary Report
on Respiratory Insufficiency

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 505 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>